CERo Therapeutics Holdings, Inc.
1 clinical trials · Sponsor
◉ Watch CERo Therapeutics Holdings, Inc.
| Record | Firm | Date |
|---|---|---|
| CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF) (NCT06834282) | CERo Therapeutics Holdings, Inc. | 2025-04-07 |
Track CERo Therapeutics Holdings, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.